Why Illumina, Inc. (ILMN) stock moved
Illumina, Inc. (ILMN) shares fell 3.8% to $226.93 as of November 2, 2026, a moderate decline from the prior close of $235.99. BestStocks flagged the session as a major change for ILMN. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for ILMN, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
ILMN fell 3.8% to $226.93
Illumina declined 2.07% to $231.10 with above-average volume (1.54x normal) 62 minutes into the session. No company-specific catalyst was identified in today's trading session; the decline occurs ahead of scheduled Q4 earnings on 2027-02-04 (consensus EPS: $1.51). A Zacks analysis flagged international revenue trends as a factor warranting investor attention. Q4 2026 earnings release on 2027-02-04; focus on international revenue growth and EPS delivery versus $1.51 consensus.
What it means for Illumina, Inc. investors
For Illumina, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Earnings beat — stock sold off (sell-the-news reaction); Illumina rallied 3.28% to $229.59, driven by a newly announced five-year collaboration with Novacyt expanding its sequencing platform into clinical diagnostics, combined with institutional positioning ahead of its S&P 500 index inclusion on September 21 (per web synthesis corroborated by Yahoo Finance reporting). Weighing against that: Negative session, down 3.8%; Illumina declined 2.07% to $231.10 with above-average volume (1.54x normal) 62 minutes into the session. Wall Street's consensus price target sits at $252.73, implying +11.4% upside from $226.93. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality low (47/100). With earnings roughly 94 days out, the next report is the most likely near-term test of the move.
ILMN price reaction
ILMN last traded at $226.93, down $9.07 (-3.84%) from the previous close of $235.99. The session traded on 0.3× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $226.93 and $293.69, and it currently sits about 0% of the way up that band.
Bullish and bearish analyst opinions on Illumina, Inc. (ILMN)
The consensus analyst price target on Illumina, Inc. (ILMN) is $252.73, 11.4% above the recent $226.93. Over the past 90 days analysts logged 1 upgrade, 10 maintains, and 0 downgrades. Here is how the bullish and bearish cases on ILMN line up.
The bullish case
- Wall Street's consensus price target of $252.73 implies +11.4% upside from $226.93.
- The Street's most bullish target is $305.00 (+34.4%).
- 1 analyst upgrade in the past 90 days, most recently UBS to Buy (2026-09-09).
- Earnings beat — stock sold off (sell-the-news reaction).
- Illumina rallied 3.28% to $229.59, driven by a newly announced five-year collaboration with Novacyt expanding its sequencing platform into clinical diagnostics, combined with institutional positioning ahead of its S&P 500 index inclusion on September 21 (per web synthesis corroborated by Yahoo Finance reporting).
The bearish case
- The most bearish analyst target is $155.00 (-31.7%).
- Negative session, down 3.8%.
- Illumina declined 2.07% to $231.10 with above-average volume (1.54x normal) 62 minutes into the session.
- Illumina filed an 8-K material event report today alongside its earnings announcement.
- Illumina shares fell 6.14% to $265.48 on light volume (0.65x average) ahead of Q3 earnings scheduled for late October.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 2, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for ILMN
In-depth ILMN event analyses
Frequently asked questions about ILMN
Why did Illumina, Inc. (ILMN) stock move?
ILMN fell 3.8% to $226.93. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did ILMN stock fall?
ILMN lost 3.84% ($9.07) versus the prior close of $235.99, last trading at $226.93 on 0.3× average volume.
When is Illumina, Inc.'s next earnings date?
ILMN's next earnings report is estimated for 2027-02-04 — about 94 days away.
What is the analyst price target for ILMN?
The consensus analyst price target for ILMN is $252.73, about 11.4% above the current $226.93. Over the past 90 days, analysts recorded 1 upgrade, 10 maintains, and 0 downgrades.
How BestStocks tracks ILMN
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared ILMN-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for ILMN, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 2, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.